---
title: Genetic screening, personalized therapy and the importance of biomarkers in medical cannabis treatment
description: Can a treatment with cannabinoids be personalized?
image: https://blog.pqegroup.com/hubfs/Genetic%20Screening_Site%20PQE.jpg
---

[![Logo PQE Group - azzurro - 2024](https://blog.pqegroup.com/hs-fs/hubfs/Logo%20PQE%20Group%20-%20azzurro%20-%202024.png?width=2000&height=721&name=Logo%20PQE%20Group%20-%20azzurro%20-%202024.png "Logo PQE Group - azzurro - 2024")](https://www2.pqegroup.com)

- [Home](https://www2.pqegroup.com/)
- [Industry](https://www2.pqegroup.com/industry/) 
    - [Pharma & API](https://www2.pqegroup.com/pharma-api/)
    - [Medical Device](https://www2.pqegroup.com/medical-device/)
    - [Biotech](https://www2.pqegroup.com/biotech/)
    - [Startup](https://www2.pqegroup.com/startup/)
    - [Veterinary](https://www2.pqegroup.com/veterinary/)
- [Services](https://www2.pqegroup.com/services/) 
    - [Data Integrity](https://www2.pqegroup.com/data-integrity/)
    - [Digital Governance](https://www2.pqegroup.com/digital-governance/)
    - [Engineering](https://www2.pqegroup.com/engineering/)
    - [Commissioning, Qualification and Validation (CQV)](https://www2.pqegroup.com/commissioning-qualification-validation/)
    - [Quality Compliance](https://www2.pqegroup.com/quality-compliance/)
    - [Laboratory Excellence](https://www2.pqegroup.com/laboratory-excellence/)
    - [Regulatory Affairs](https://www2.pqegroup.com/regulatory-affairs/)
    - [Audits](https://www2.pqegroup.com/audits/)
    - [Training](https://www2.pqegroup.com/training/)
    - [Clinical Research](https://www2.pqegroup.com/clinical-research-services/)
    - [Pharmacovigilance](https://www2.pqegroup.com/pharmacovigilance/)
- About 
    - [About Us](https://www2.pqegroup.com/about/)
    - [ESG](https://www2.pqegroup.com/about/csr/)
    - [Women in STEM](https://www2.pqegroup.com/about/women-in-stem/)
- Resources 
    - [News & Press](https://www2.pqegroup.com/news/)
    - [Webinars](https://www2.pqegroup.com/webinars/)
    - [Blog](https://blog.pqegroup.com/)
- [Careers](https://www2.pqegroup.com/careers/)
- [Contact Us](https://www2.pqegroup.com/contact-us/)

![](https://blog.pqegroup.com/hubfs/blank-user.png)

Dominik Marko

Director of Scientific Affairs, and Chemistry & Biology expert

# **Genetic screening, personalized therapy and the importance of biomarkers in medical cannabis treatment**

[Medical Cannabis](https://blog.pqegroup.com/tag/medical-cannabis)

Despite the use of cannabis in medicine stretching back hundreds of years, the modern integration and application of medical cannabis into the global health system have been off to a rocky start. While efforts to legalize medical cannabis are underway in most parts of the world, the misconceptions about how medical cannabis works have made it challenging for medical professionals to fully embrace its use and for patients to access it as a viable treatment option. In addition, the lack of quality and reliable data on the efficacy of medical cannabis and standardized testing has led to discrepancies in quality, dosage, and safety, further complicating its integration into mainstream healthcare. 

## Debunking The “One Dose For All” Misconception Using Genetic Screening 

One of the common misconceptions about medical cannabis treatment is that people require and should respond universally to the same dose. Clinical trials have shown this not to be accurate, as the genetic differences in our DNA coupled with factors like age and enzymes  have been shown to play a vital role in how our bodies react to medical cannabis. Due to these variables, the way patient A might respond to a lower dose might be different from how patient B reacts to the same dose, which means that to get the desired outcome in both patients, depending on their DNA and how their enzymes metabolize cannabinoids, one patient might require a higher dose to achieve the same result as the patient responding well to a lower dose.  

## How Metabolism Plays A Dominant Role In Determining Dosage 

The speed at which your enzymes metabolize cannabinoids is a crucial determinant of the dosage required to achieve the desired outcome when using medical cannabis. The bodies of patients with higher levels of enzymes can metabolize both THC and CBD faster than those with lower enzymes, which means that for medical cannabis to work effectively in these patients, a higher dose is required to cope with the high rate at which cannabinoids are being metabolized. What genetic screening helps medical practitioners achieve is essentially the expression levels of according enzymes in a patient’s body to prescribe the correct dose. Biomarkers assist in this regard by telling the rate at which a patient’s enzymes metabolize cannabinoids to help decide whether a higher or lower dosage is required for the patient. 

Since higher levels of enzymes speed up the degradation of target molecules, patients with higher enzymes often experience a short duration of phytocannabinoids effect compared to patients with lower enzymes, hence the recommended higher dosage. 

[Read the full article on GQC website](https://glocalqualitycannabis.com/blog/genetic-screening-personalized-therapy-and-the-importance-of-biomarkers-in-medical-cannabis-treatment/)

![Genetic Screening_Site PQE](https://blog.pqegroup.com/hubfs/Genetic%20Screening_Site%20PQE.jpg)

## Want to know more?

Visit [GQC - Glocal Quality Cannabis](https://glocalqualitycannabis.com/) website, our Medical Cannabis dedicated company

Our experts can support you through every stage of **cultivation** and **extraction**.  
We will make sure you fully meet the compliance standards set in your country for greenhouses and laboratories and we will help you register your product and sell it in different countries.

[Connect with us](https://glocalqualitycannabis.com/contacts/)

#### More on this topic

[Medical Cannabis ![What conditions are most commonly treated with medical cannabis?](https://blog.pqegroup.com/hubfs/PQE%20The%20expert%20Voice-Pharmacy-%20Quest_12-13.jpg)](https://blog.pqegroup.com/medical-cannabis/what-conditions-are-most-commonly-treated-with-medical-cannabis)

 27 Nov 2024

## [What conditions are most commonly treated with medical cannabis? Medical cannabis is commonly used for pain management, oncological symptoms, anxiety and neurodegenerative diseases.](https://blog.pqegroup.com/medical-cannabis/what-conditions-are-most-commonly-treated-with-medical-cannabis)

[Medical Cannabis ![Safety Risks in Unregulated Cannabis Production](https://blog.pqegroup.com/hubfs/Safety%20Risks_Site%20PQE.jpg)](https://blog.pqegroup.com/medical-cannabis/safety-risks-in-unregulated-cannabis-production)

 21 Nov 2024

## [Safety Risks in Unregulated Cannabis Production Explore the health risks of contaminated cannabis and the need for strict quality controls to ensure consumer safety.](https://blog.pqegroup.com/medical-cannabis/safety-risks-in-unregulated-cannabis-production)

[Medical Cannabis ![How many medical cannabis patients do you have to manage in terms of numbers and how many of their needs can you satisfy?](https://blog.pqegroup.com/hubfs/PQE%20The%20expert%20Voice-Pharmacy-%20Quest_10-11.jpg)](https://blog.pqegroup.com/medical-cannabis/how-many-medical-cannabis-patients-do-you-have-to-manage-in-terms-of-numbers-and-how-many-of-their-needs-can-you-satisfy)

 24 Oct 2024

## [How many medical cannabis patients do you have to manage in terms of numbers and how many of their needs can you satisfy? Our team works closely with doctors and engages with patients daily, offering guidance on therapy use and managing drug interactions](https://blog.pqegroup.com/medical-cannabis/how-many-medical-cannabis-patients-do-you-have-to-manage-in-terms-of-numbers-and-how-many-of-their-needs-can-you-satisfy)

![new PQE logo white tagline](https://blog.pqegroup.com/hubfs/new%20PQE%20logo%20white%20tagline.png)

ISO 9001 Certified compliance services provider since 1998.

 

![Logo ISO 9001](https://blog.pqegroup.com/hs-fs/hubfs/Logo%20ISO%209001.png?width=125&name=Logo%20ISO%209001.png)

 

- Discover PQE 
    - [Work with PQE](https://www2.pqegroup.com/careers/)
    - [Locations](https://www2.pqegroup.com/contact-us/#locations)
    - [About](https://www2.pqegroup.com/about/)
    - [Blog](https://blog.pqegroup.com/)

- Useful Links 
    - [Privacy Notice](https://www2.pqegroup.com/privacy-notice/)
    - [Cookie Policy](https://www2.pqegroup.com/cookie-policy/)
    - [Model of Organization](https://www2.pqegroup.com/model-of-organization/)
    - [Ethical Code](https://www2.pqegroup.com/ethical-code/)

English

- [English](https://blog.pqegroup.com/medical-cannabis/genetic-screening-personalized-therapy-and-the-importance-of-biomarkers-in-medical-cannabis-treatment/)
- [Español - España](https://blog.pqegroup.com/es-es/cannabis-medicinal/analisis-genetico-terapia-personalizada-importancia-de-marcadores-biologicos-en-tratamientos-con-cannabis)
- [Español - México](https://blog.pqegroup.com/es-mx/cannabis-medicinal/tamizaje-genetico-terapia-personalizada-importancia-de-marcadores-biologicos-en-tratamientos-con-cannabis)
- [Português - Brasil](https://blog.pqegroup.com/pt-br/cannabis-medicinal/triagem-genetica-terapia-personalizada)

CHANGE LANGUAGE

Copyright **2024** | Proudly powered by **PQE Group Creative Team**

[LinkedIn](https://www.linkedin.com/company/pqe-group) [![twitter](https://blog.pqegroup.com/hubfs/twitter-w.png) Twitter](https://twitter.com/PQEGroup) [Facebook](https://www.facebook.com/PQEGroup/) [Instagram](https://www.instagram.com/lifeatpqe) [YouTube](https://www.youtube.com/c/PQEGroup) [Xing](https://www.xing.com/pages/pqegroup)